Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy

NCT01267422 is registered in ClinicalTrials.gov with Bin Li as lead sponsor.

NCT NCT01267422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01267422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy
Lead sponsor
Bin Li
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
November 30, 2015
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leber hereditary optic neuropathy